BBG Meeting Brighton | 22nd June – 23rd 2023
Mercure Brighton Seafront Hotel, 149 King's Road, Brighton BN1 2PP
The 2023 BBG meeting took place in Brighton on Thursday 22nd and Friday 23rd June at the Mercure Hotel in Brighton and was an excellent meeting with something for everyone.
Our two plenary speakers (Anna Kirby – Controversies in diagnosis and management of oligometastatic disease and Lesley Fallowfield – Communication – Past, present and future) on the Thursday afternoon gave outstanding talks to start the meeting. The BBG dinner was attended by more than 70 members and guests. The good food and wine was supplemented by an after dinner speech from David Dodwell delivered with his usual wry sense of humour and some exciting live entertainment from the award winning accapella band Naked Voices.
The main meeting on Friday provided a wonderful mix of plenary talks from leading experts in their field including Fiona Gilbert who provided an exciting glimpse into the future of the use of artificial Intelligence in breast imaging, Peter Schmid reviewing the remarkable progress in the use of immunotherapy in breast cancer and Stuart McIntosh who addressed the challenging topic of de-escalation of loco-regional treatments.
Abstract presentations provided a truly multidisciplinary mix of topics reflecting the unique nature and great strength of the BBG meetings. All presentations were of a very high quality and prompted lively discussion. The presentation from CarolynTaylor on breast cancer mortality in 500,000 women diagnosed with early invasive breast cancer in England illustrated just how dramatically the outcome for patients has improved over the past 30 years.
Our thanks go to the local organising team, Holly Cowlan, Melanie Flint and Lesley Fallowfield for ensuring the local arrangements and to David Dodwell and Rob Coleman for programme development and meeting oversight.
Next year’s meeting will be held in late June or July 2024 in Manchester hosted by Sacha Howell and Rob Clarke. Further information will be provide in the autumn.
BRITISH BREAST GROUP 2023 MEETING PROGRAMME
| Thursday 22nd June 2023 |
| SESSION 1: Challenging Problems in Breast Cancer Care – CHAIR: David Dodwell |
| 17.20 | Controversies in diagnosis and management of oligometastatic disease | Plenary speaker – Anna Kirby |
| 17.55 | Communication – Past, present and future | Plenary speaker – Lesley Fallowfield
|
| Friday 23rd June 2023 |
| 08.30 | AGM – Members only | |
| ||
| SESSION 2: CHAIR: Robert Coleman | ||
| 09.45 | Exploring the experiences of women denied immediate breast REconstruction after maSTectOmy for bREast cancer during the COVID-19 pandemic – The RESTORE C19 qualitative study | Katherine Fairhurst, Rajiv Dave, Rachel O’Connell, Raghavan Vidya, Patricia Fairbrother, Jo Skillman, Leila Rooshenas, Shelley Potter |
| 10.05 | Genetic predisposition – decision making in the face of uncertainty | Diana Eccles, Kelly Kohut, Kate Morton, Lesley Turner, Claire Foster |
| 10.25 | Use of artificial Intelligence in breast imaging | Plenary speaker- Fiona Gilbert |
| 10.55 | HORMAD1 as a biomarker of BRCAness and platinum-sensitivity in breast cancer | J. Quist, L.W. de Boo, H. Tovey, K. Jóźwiak, M. Raghunandan, O. Sipos, P. Gazinska, M. Opdam,T. Hardiman, N. Janghra, C. Liu, M. Cheang, J. Bliss, D. Peters, H.M. Horlings, T.G.Steenbruggen, L.C. Steggink, E.G.E. de Vries, G.S. Sonke, J.A. Gietema, C.J. Lord, J. Staaf, M. Kok, A.N.J. Tutt, S.C. Linn, A. Grigoriadis |
| 11.15 | Anthracyclines induce cGAS-STING dependent inflammation and immune checkpoint induction in breast cancer | Savage, KI, Barros, EM, Wilkinson, RDA, McCabe, N, Johnston, DI, Lappin, K, Greenberg, RA, Harkin, DP, McIntosh, SA, Kennedy, RD. |
| 11.35 | Computerized Quantification of Tumor Infiltrating Lymphocyte (TIL) as a prognostic and predictive factor in ductal carcinoma in situ: Results from the UK/ANZ DCIS randomized trial. | Mangesh Thorat, Haojia Li, Paula Toro, Mojgan Mokhtari, PingFu Fu, Sunil S Badve, Jack Cuzick, Anant Madabhushi |
| 11.55 | Immunotherapy in breast cancer – Where does the pendulum of enthusiasm currently sit? | Plenary speaker – Peter Schmid |
| Session 3: CHAIR: Peter Barrett-Lee | ||
| 13.30 | Breast cancer mortality in 500,000 women diagnosed with early invasive breast cancer in England | Carolyn Taylor, Paul McGale, Jake Probert , John Broggio, Jackie Charman, Sarah Darby, David Cutter, Gurdeep Mannu, David Dodwell) |
| 14.00 | Metformin is associated with increased tumour infiltrating immune cells in patients with primary breast cancer. | Constantinos Savva, Charles Birts, Russell Foxall, Margaret Ashton-Key, Alastair Thompson, Simon Lord, Leticia Campo, Sirwan Hadad, Colin Purdie, Peter Johnson, Ellen Copson, Ramsey Cutress, Stephen Beers. |
| 14.20 | Progesterone Receptor Antagonism in breast cancer prevention | Sacha Howell, Rob Pedley, Curtis McCloskey, Matt Roberts, Alice Greenhalgh, Suad Alghamdi, Amanda Caruso, Martina Forestiero, Jesica Lopez, Jasmin Roche, Ren Jie, Muhammad A. Khan, James McConnell, Steven Squires, Sue Astley, Elaine Harkness, Yit Lim, Alecia-Jane Twigger, Lucy Osborne, Michael Sherratt, Sebastiano Ando, Anthony Howell, Gareth Evans, Andrew Gilmore, Walid Khaled, Rama Khokha, Robert Clarke, Bruno Simões |
| 14.40 | Local treatment de-escalation | Plenary speaker – Stuart McIntosh |
| 15.10 | Surgical outcomes of neoadjuvant endocrine treatment: A Systematic Review and Meta-analysis | Ramsey Cutress, Constantinos Savva, Beatrice Brett, Bahar Mirshekar-Syahkal, Ellen Copson, Martyn Hill and Michael Douek |
| 15.30 | Immediate post-mastectomy alloplastic breast reconstruction as a day case procedure and impact of the COVID-19 pandemic | Nidhi Garg, Mangesh Thorat, Amar Deshpande |
| The British Breast Group wish to acknowledge the support from Roche, Exact Sciences and Gilead who provided support for the provision of the venue and catering for this meeting but had no input into the content or agenda of this meeting. | ||
* Includes delegates who have applied for membership by 30th April 2023 and who are awaiting confirmation at this year’s AGM
‡ Includes clinicians in training, research students and scientists at to below lecturer level
CANCELLATION CLAUSE – British Breast Group Meeting – Please note the British Breast Group only charges members the cost for the accommodation and meeting venue (with a small administration fee) and any loss, due to late cancellations, have in the past been paid out of the BBG account. The BBG committee believes that this is not a good use of BBG funds and will endeavour to recoup all late cancellation charges for future meetings. Therefore, the BBG will be unable to refund any cancellations, however, places can be transferred to colleagues up to the date of the meeting but all places booked (including meeting only), and not filled, will be subject to the full fee. If for any reason the meeting cancelled is due to unforeseen circumstances (i.e. weather) the registration fees will be subject to full payment. In the event that the meeting is postponed due to COVID the BBG would endeavour to transfer the registration to an alternative date but would not be able to reimburse. payments that were not refunded by the hotel.